Thomas J Schnitzer

Grants

Grants per year 2002 2004 2005 2006 2007 2008 2009 2010 2012 2015 2016 2019 2020 2024

• 19 Active
• 80 Finished

Grants per year

Search results

• Active

  Prot #TF-X0002-31: A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects with Osteoarthritis of t

  Schnitzer, T. J.

  Premier Research International, LLC, Techfields, Inc.

  10/15/21 → 10/15/24

  Project: Research project

• Transcranial Magnetic Stimulation to Enhance Cortical-Hippocampal Functional Connectivity as a Novel Means for Relieving Chronic OA Pain

  Apkarian, A., Schnitzer, T. J. & Voss, J. L.

  Pfizer Inc.

  5/24/21 → 5/23/22

  Project: Research project

• Prot #CDFV890B12201: A Randomized, Two-arm, Placebo-controlled, Participant and Investigator-Blinded Study Investigating the Efficacy, Safety and Tolerability of DFV890 in Patients with Symptomatic Knee Osteoarthritis

  Schnitzer, T. J.

  Novartis Pharmaceuticals Corporation

  4/1/21 → 11/30/23

  Project: Research project

• Prot #20197268: Effects of Romosozumab on Bone Health in Women with Spinal Cord Injury and Osteoporosis

  Schnitzer, T. J.

  Amgen, Inc.

  12/21/20 → 12/21/23

  Project: Research project

• Prot #Cingal 19-01: A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

  Schnitzer, T. J.

  SynteractHCR, Inc., Anika Therapeutics, Inc.

  9/11/20 → 9/11/23

  Project: Research project

• Data Center for Acute to Chronic Pain Biosignatures

  Apkarian, A., Griffith, J. W. & Schnitzer, T. J.

  Johns Hopkins University, National Institute on Drug Abuse

  8/1/20 → 7/31/23

  Project: Research project

  • Neuroimaging 100%
  • Metadata 75%

• Prot #H0P-MC-CPMP: A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain

  Schnitzer, T. J.

  Lilly USA, LLC

  7/29/20 → 7/29/23

  Project: Research project

• Prot #TLC599A3005: A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee

  Schnitzer, T. J.

  Premier Research International, LLC, Taiwan Liposome Company, Ltd

  6/25/20 → 6/25/23

  Project: Research project

• Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J.

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  5/14/19 → 5/14/22

  Project: Research project

• Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

  2/21/19 → 2/21/22

  Project: Research project

• Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

  Schnitzer, T. J.

  Flexion Therapeutics, Inc.

  2/6/19 → 2/6/22

  Project: Research project

• Brain Pathophysiology of Osteoarthritis Pain

  Apkarian, A., Griffith, J. W., Kahnt, T., Manning, D. W., Parrish, T. B. & Schnitzer, T. J.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/1/19 → 12/31/23

  Project: Research project

  • Osteoarthritis 100%
  • Pain 62%
  • Chronic Pain 40%
  • Brain 38%
  • Knee Osteoarthritis 29%

• Prot #TGC-15302/KTG-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Effectiveness of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

  Schnitzer, T. J.

  Parexel, Kolon TissueGene, Inc.

  1/28/19 → 1/28/24

  Project: Research project

• Center for chronic pain and drug abuse

  Apkarian, A., Drenan, R. M., Graves, S. M., Griffith, J. W., Huang, L., Jovasevic, V., Miller, R. J., Parrish, T. B., Procissi, D., Rodes, M. E., Schnitzer, T. J., Awatramani, R., Martina, M., Radulovic, J. & Surmeier Jr, D. J.

  National Institute on Drug Abuse

  9/1/18 → 6/30/23

  Project: Research project

  • Chronic Pain 100%
  • Opioid Analgesics 67%
  • Substance-Related Disorders 55%
  • Opioid-Related Disorders 27%
  • Brain 22%

• Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Radius Health, Inc.

  6/13/18 → 6/13/22

  Project: Research project

• D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

  Schnitzer, T. J., Apkarian, A. & Griffith, J. W.

  U.S. Army Medical Research and Materiel Command

  9/30/17 → 9/29/22

  Project: Research project

  • Cycloserine 100%
  • Chronic Pain 80%
  • Back Pain 54%
  • Low Back Pain 47%
  • Pain 30%

• Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

  Schnitzer, T. J.

  Worldwide Clinical Trials, Inc., Grunenthal GmbH

  1/17/17 → 1/17/22

  Project: Research project

• Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  5/12/16 → 5/12/22

  Project: Research project

• Prot #A4091058: A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/25/15 → 8/31/22

  Project: Research project

• Finished

  Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

  Schnitzer, T. J.

  Medpace Clinical Research LLC, Galapagos NV

  12/4/18 → 12/4/21

  Project: Research project

• Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • Bone and Bones 100%
  • Spinal Cord Injuries 94%
  • Teriparatide 86%
  • Alendronate 40%
  • Therapeutics 22%

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Apkarian, A., Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J. & Surmeier Jr, D. J.

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Apkarian, A., Cella, D., Gershon, R., Parrish, T. B., Schnitzer, T. J. & Griffith, J. W.

  National Center for Complementary and Integrative Health

  6/1/16 → 5/31/18

  Project: Research project

• Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/15/16 → 11/30/20

  Project: Research project